Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T21:23:17.595Z.
Calculation as of: 2026-10-06T21:23:17.595Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e4092e053989caac2e99517ddb979985c78622fc494c6088febce458b2dbbcab
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-03-09.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
884.25
PS RATIO AVG 3Y
13.16
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$265.78M
PS Ratio
95.29
TTM Avg
82.20
3Y Avg
35.74
5Y Avg
24.54
Market Cap
$262.92M
PS Ratio
5.83
TTM Avg
5.30
3Y Avg
6.28
5Y Avg
18.85
Market Cap
$261.43M
PS Ratio
N/A
TTM Avg
8336935.98
3Y Avg
3234328.97
5Y Avg
2173022.38
Market Cap
$261.27M
PS Ratio
16.49
TTM Avg
22.58
3Y Avg
53.44
5Y Avg
53.44
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | $266.59M | N/A | 884.25 | 13.16 | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | 41.12 | 30.89 | 23.00 | 28.64 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | 95.29 | 82.20 | 35.74 | 24.54 |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | 5.83 | 5.30 | 6.28 | 18.85 |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | 8336935.98 | 3234328.97 | 2173022.38 |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | 1.26 | 1.73 | 1.50 | 1.77 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | 16.49 | 22.58 | 53.44 | 53.44 |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | 2.31 | 1.95 | 1.47 | 1.49 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-03-09 | 2606.80 |
| 2026-03-06 | 2572.86 |
| 2026-03-05 | 2586.44 |
| 2026-03-04 | 2667.90 |
| 2026-03-03 | 2640.74 |
| 2026-03-02 | 2762.94 |
| 2026-02-27 | 2783.30 |
| 2026-02-26 | 2803.67 |
| 2026-02-25 | 2667.90 |
| 2026-02-24 | 2538.92 |
| 2026-02-23 | 2491.40 |
| 2026-02-20 | 2423.51 |
| 2026-02-19 | 2572.86 |
| 2026-02-18 | 2538.92 |
| 2026-02-17 | 2633.96 |
| 2026-02-13 | 2613.59 |
| 2026-02-12 | 2796.88 |
| 2026-02-11 | 2837.61 |
| 2026-02-10 | 2837.61 |
| 2026-02-09 | 2871.55 |
| 2026-02-06 | 2830.82 |
| 2026-02-05 | 2701.84 |
| 2026-02-04 | 2871.55 |
| 2026-02-03 | 3020.90 |
| 2026-02-02 | 2973.38 |
| 2026-01-30 | 2980.17 |
| 2026-01-29 | 3000.54 |
| 2026-01-28 | 2993.75 |
| 2026-01-27 | 2905.50 |
| 2026-01-26 | 2803.67 |
| 2026-01-23 | 2742.57 |
| 2026-01-22 | 2715.42 |
| 2026-01-21 | 2735.78 |
| 2026-01-20 | 2722.21 |
| 2026-01-16 | 2701.84 |
| 2026-01-15 | 2715.42 |
| 2026-01-14 | 2715.42 |
| 2026-01-13 | 2674.69 |
| 2026-01-12 | 2538.92 |
| 2026-01-09 | 2498.18 |
| 2026-01-08 | 2620.38 |
| 2026-01-07 | 2695.05 |
| 2026-01-06 | 2457.45 |
| 2026-01-05 | 2538.92 |
| 2026-01-02 | 2559.28 |
| 2025-12-31 | 2538.92 |
| 2025-12-30 | 2559.28 |
| 2025-12-29 | 2477.82 |
| 2025-12-26 | 2566.07 |
| 2025-12-24 | 2606.80 |
| 2025-12-23 | 2606.80 |
| 2025-12-22 | 2606.80 |
| 2025-12-19 | 2708.63 |
| 2025-12-18 | 2681.48 |
| 2025-12-17 | 2688.26 |
| 2025-12-16 | 2708.63 |
| 2025-12-15 | 2715.42 |
| 2025-12-12 | 2586.44 |
| 2025-12-11 | 2437.09 |
| 2025-12-10 | 2518.55 |
| 2025-12-09 | 2552.49 |
| 2025-12-08 | 2409.93 |
| 2025-12-05 | 2701.84 |
| 2025-12-04 | 2579.65 |
| 2025-12-03 | 2511.76 |
| 2025-12-02 | 2471.03 |
| 2025-12-01 | 2572.86 |
| 2025-11-28 | 2681.48 |
| 2025-11-26 | 2742.57 |
| 2025-11-25 | 2667.90 |
| 2025-11-24 | 2729.00 |
| 2025-11-21 | 2681.48 |
| 2025-11-20 | 2579.65 |
| 2025-11-19 | 2600.01 |
| 2025-11-18 | 2654.32 |
| 2025-11-17 | 2375.99 |
| 2025-11-14 | 2199.49 |
| 2025-11-13 | 251.21 |
| 2025-11-12 | 276.33 |
| 2025-11-11 | 264.98 |
| 2025-11-10 | 259.31 |
| 2025-11-07 | 259.31 |
| 2025-11-06 | 251.21 |
| 2025-11-05 | 257.69 |
| 2025-11-04 | 263.36 |
| 2025-11-03 | 263.36 |
| 2025-10-31 | 263.36 |
| 2025-10-30 | 243.91 |
| 2025-10-29 | 246.34 |
| 2025-10-28 | 244.72 |
| 2025-10-27 | 245.53 |
| 2025-10-24 | 245.53 |
| 2025-10-23 | 236.62 |
| 2025-10-22 | 243.10 |
| 2025-10-21 | 243.10 |
| 2025-10-20 | 243.10 |
| 2025-10-17 | 203.40 |
| 2025-10-16 | 175.84 |
| 2025-10-15 | 190.43 |
| 2025-10-14 | 186.38 |
| 2025-10-13 | 187.19 |
| 2025-10-10 | 185.57 |
| 2025-10-09 | 202.59 |
| 2025-10-08 | 189.62 |
| 2025-10-07 | 189.62 |
| 2025-10-06 | 185.57 |
| 2025-10-03 | 166.93 |
| 2025-10-02 | 162.88 |
| 2025-10-01 | 160.45 |
| 2025-09-30 | 162.88 |
| 2025-09-29 | 158.02 |
| 2025-09-26 | 162.88 |
| 2025-09-25 | 170.17 |
| 2025-09-24 | 175.03 |
| 2025-09-23 | 183.14 |
| 2025-09-22 | 200.96 |
| 2025-09-19 | 200.15 |
| 2025-09-18 | 226.09 |
| 2025-09-17 | 209.07 |
| 2025-09-16 | 174.22 |
| 2025-09-15 | 170.17 |
| 2025-09-12 | 171.79 |
| 2025-09-11 | 171.79 |
| 2025-09-10 | 172.60 |
| 2025-09-09 | 172.60 |
| 2025-09-08 | 170.17 |
| 2025-09-05 | 183.95 |
| 2025-09-04 | 183.14 |
| 2025-09-03 | 188.00 |
| 2025-09-02 | 171.79 |
| 2025-08-29 | 168.55 |
| 2025-08-28 | 170.17 |
| 2025-08-27 | 171.79 |
| 2025-08-26 | 175.84 |
| 2025-08-25 | 179.90 |
| 2025-08-22 | 177.47 |
| 2025-08-21 | 166.93 |
| 2025-08-20 | 162.88 |
| 2025-08-19 | 162.07 |
| 2025-08-18 | 176.65 |
| 2025-08-15 | 179.90 |
| 2025-08-14 | 179.09 |
| 2025-08-13 | 174.22 |
| 2025-08-12 | 175.03 |
| 2025-08-11 | 163.69 |
| 2025-08-08 | 178.28 |
| 2025-08-07 | 54.84 |
| 2025-08-06 | 53.86 |
| 2025-08-05 | 56.56 |
| 2025-08-04 | 56.07 |
| 2025-08-01 | 54.84 |
| 2025-07-31 | 46.23 |
| 2025-07-30 | 55.58 |
| 2025-07-29 | 55.83 |
| 2025-07-28 | 62.22 |
| 2025-07-25 | 62.71 |
| 2025-07-24 | 63.94 |
| 2025-07-23 | 61.24 |
| 2025-07-22 | 64.19 |
| 2025-07-21 | 66.40 |
| 2025-07-18 | 63.20 |
| 2025-07-17 | 69.84 |
| 2025-07-16 | 68.61 |
| 2025-07-15 | 62.47 |
| 2025-07-14 | 66.15 |
| 2025-07-11 | 63.94 |
| 2025-07-10 | 61.48 |
| 2025-07-09 | 62.71 |
| 2025-07-08 | 63.45 |
| 2025-07-07 | 48.20 |
| 2025-07-03 | 42.30 |
| 2025-07-02 | 43.04 |
| 2025-07-01 | 43.28 |
| 2025-06-30 | 43.28 |
| 2025-06-27 | 41.56 |
| 2025-06-26 | 43.78 |
| 2025-06-25 | 44.76 |
| 2025-06-24 | 44.27 |
| 2025-06-23 | 43.28 |
| 2025-06-20 | 44.02 |
| 2025-06-18 | 43.78 |
| 2025-06-17 | 43.78 |
| 2025-06-16 | 41.81 |
| 2025-06-13 | 42.05 |
| 2025-06-12 | 45.00 |
| 2025-06-11 | 46.23 |
| 2025-06-10 | 45.99 |
| 2025-06-09 | 45.74 |
| 2025-06-06 | 44.51 |
| 2025-06-05 | 45.00 |
| 2025-06-04 | 45.99 |
| 2025-06-03 | 45.74 |
| 2025-06-02 | 47.22 |
| 2025-05-30 | 47.46 |
| 2025-05-29 | 44.51 |
| 2025-05-28 | 43.28 |
| 2025-05-27 | 43.78 |
| 2025-05-23 | 44.51 |
| 2025-05-22 | 45.74 |
| 2025-05-21 | 42.05 |
| 2025-05-20 | 45.25 |
| 2025-05-19 | 44.27 |
| 2025-05-16 | 45.50 |
| 2025-05-15 | 47.71 |
| 2025-05-14 | 45.50 |
| 2025-05-13 | 46.23 |
| 2025-05-12 | 48.69 |
| 2025-05-09 | 12.54 |
| 2025-05-08 | 12.05 |
| 2025-05-07 | 11.84 |
| 2025-05-06 | 11.70 |
| 2025-05-05 | 11.91 |
| 2025-05-02 | 11.21 |
| 2025-05-01 | 11.91 |
| 2025-04-30 | 11.91 |
| 2025-04-29 | 11.63 |
| 2025-04-28 | 12.54 |
| 2025-04-25 | 12.26 |
| 2025-04-24 | 10.51 |
| 2025-04-23 | 9.60 |
| 2025-04-22 | 9.11 |
| 2025-04-21 | 10.02 |
| 2025-04-17 | 10.09 |
| 2025-04-16 | 9.74 |
| 2025-04-15 | 9.67 |
| 2025-04-14 | 9.74 |
| 2025-04-11 | 8.61 |
| 2025-04-10 | 8.26 |
| 2025-04-09 | 8.89 |
| 2025-04-08 | 8.05 |
| 2025-04-07 | 7.77 |
| 2025-04-04 | 7.91 |
| 2025-04-03 | 8.26 |
| 2025-04-02 | 8.75 |
| 2025-04-01 | 8.61 |
| 2025-03-31 | 9.53 |
| 2025-03-28 | 9.06 |
| 2025-03-27 | 9.49 |
| 2025-03-26 | 9.36 |
| 2025-03-25 | 9.92 |
| 2025-03-24 | 9.79 |
| 2025-03-21 | 10.53 |
| 2025-03-20 | 9.73 |
| 2025-03-19 | 9.92 |
| 2025-03-18 | 9.49 |
| 2025-03-17 | 9.92 |
| 2025-03-14 | 9.85 |
| 2025-03-13 | 9.98 |
| 2025-03-12 | 9.79 |
| 2025-03-11 | 9.30 |
| 2025-03-10 | 9.55 |
| 2025-03-07 | 9.92 |
| 2025-03-06 | 9.98 |
| 2025-03-05 | 10.41 |
| 2025-03-04 | 9.55 |
| 2025-03-03 | 9.55 |
| 2025-02-28 | 10.47 |
| 2025-02-27 | 10.34 |
| 2025-02-26 | 10.71 |
| 2025-02-25 | 10.65 |
Showing the most recent 260 of 1,075 data points. The chart above shows the full history.
